Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and Carcinoma, Hepatocellular

levofloxacin has been researched along with Carcinoma, Hepatocellular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khalifa, MO; Mansour, MA1
Ebisutani, C; Inoue, H; Kinoshita, Y; Nishi, K; Sato, S; Yoshie, T1

Trials

2 trial(s) available for levofloxacin and Carcinoma, Hepatocellular

ArticleYear
Antibiotic prophylaxis in transarterial chemoembolization of hepatocellular carcinoma.
    Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2018, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Carcinoma, Hepatocellular; Catheterization, Peripheral; Ceftriaxone; Chemoembolization, Therapeutic; Ciprofloxacin; Drug Administration Routes; Drug Monitoring; Egypt; Female; Humans; Levofloxacin; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Treatment Outcome

2018
Antibiotic prophylaxis in transcatheter treatment of hepatocellular carcinoma: an open randomized prospective study of oral versus intravenous administration.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:12

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Carcinoma, Hepatocellular; Cefazolin; Chemoembolization, Therapeutic; Female; Humans; Inflammation Mediators; Infusions, Intra-Arterial; Infusions, Intravenous; Levofloxacin; Liver Neoplasms; Male; Middle Aged; Ofloxacin; Postoperative Complications; Prospective Studies; Treatment Outcome

2010